litlas
ログインアカウント作成

Rolf Kiessling

1975–2024 年に発表

126
論文数
24,145
被引用数
90
h 指数
126
i10 指数

被引用数

Rolf Kiessling の年別被引用数1975 年: 被引用 14 件1976 年: 被引用 33 件1977 年: 被引用 56 件1978 年: 被引用 56 件1979 年: 被引用 85 件1980 年: 被引用 72 件1981 年: 被引用 69 件1982 年: 被引用 49 件1983 年: 被引用 31 件1984 年: 被引用 28 件1985 年: 被引用 37 件1986 年: 被引用 20 件1987 年: 被引用 39 件1988 年: 被引用 8 件1989 年: 被引用 57 件1990 年: 被引用 38 件1991 年: 被引用 38 件1992 年: 被引用 27 件1993 年: 被引用 40 件1994 年: 被引用 37 件1995 年: 被引用 35 件1996 年: 被引用 70 件1997 年: 被引用 75 件1998 年: 被引用 72 件1999 年: 被引用 110 件2000 年: 被引用 94 件2001 年: 被引用 140 件2002 年: 被引用 179 件2003 年: 被引用 148 件2004 年: 被引用 172 件2005 年: 被引用 182 件2006 年: 被引用 154 件2007 年: 被引用 138 件2008 年: 被引用 161 件2009 年: 被引用 131 件2010 年: 被引用 118 件2011 年: 被引用 177 件2012 年: 被引用 187 件2013 年: 被引用 187 件2014 年: 被引用 199 件2015 年: 被引用 244 件2016 年: 被引用 198 件2017 年: 被引用 194 件2018 年: 被引用 210 件2019 年: 被引用 536 件2020 年: 被引用 618 件2021 年: 被引用 592 件2022 年: 被引用 472 件2023 年: 被引用 358 件2024 年: 被引用 484 件2025 年: 被引用 247 件2026 年: 被引用 8 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,488 件、この内訳の 28.3%中国: 引用元論文 974 件、この内訳の 11.1%ドイツ: 引用元論文 578 件、この内訳の 6.6%イギリス: 引用元論文 443 件、この内訳の 5.1%スウェーデン: 引用元論文 427 件、この内訳の 4.9%イタリア: 引用元論文 419 件、この内訳の 4.8%フランス: 引用元論文 355 件、この内訳の 4%日本: 引用元論文 276 件、この内訳の 3.1%オランダ: 引用元論文 261 件、この内訳の 3%カナダ: 引用元論文 230 件、この内訳の 2.6%オーストラリア: 引用元論文 197 件、この内訳の 2.2%スペイン: 引用元論文 174 件、この内訳の 2%
0%28.3%その他 22.3%

機関

分野

  • Immunology and Microbiology50%
  • Medicine31.5%
  • Biochemistry, Genetics and Molecular Biology14.5%
  • Engineering1%
  • Neuroscience0.9%
  • Nursing0.5%
  • その他1.6%

トピック

  • Immune Cell Function and Interaction13.4%
  • Immunotherapy and Immune Responses7.7%
  • T-cell and B-cell Immunology6.6%
  • CAR-T cell therapy research6.3%
  • Cancer Immunotherapy and Biomarkers6.1%
  • Immune cells in cancer5.2%
  • その他54.7%

共著者

全論文

検索で開く
  1. Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

    著者: Klas Kärre, Hans Ljunggren, Gerald E. Piontek, Rolf Kiessling - Nature 1986 被引用: 2,152

  2. Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells

    著者: Silke Eisinger, Dhifaf Sarhan, Vanessa F. Boura, Itziar Ibarlucea-Benitez, Sofia Tyystjärvi, Ganna Oliynyk, Marie Arsenian‐Henriksson, David P. Lane, Stina L. Wikström, Rolf Kiessling, Tommaso Virgilio, Santiago González, Dagmara Kaczyńska, Shigeaki Kanatani, Evangelia Daskalaki, Craig E. Wheelock, Saikiran K. Sedimbi, Benedict J. Chambers, Jeffrey V. Ravetch, Mikael C. I. Karlsson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 被引用: 176

  3. Counteracting CAR T cell dysfunction

    著者: Mansour Poorebrahim, Jeroen Melief, Yago Pico de Coaña, Stina L. Wickström, Ángel Cid-Arregui, Rolf Kiessling - Oncogene 2020 被引用: 166

  4. „Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

    著者: Rolf Kiessling, Eva Klein, Hans Wigzell - European Journal of Immunology 1975 被引用: 1,784

  5. Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress

    著者: Stefanie Renken, Takahiro Nakajima, Isabelle Magalhaes, Jonas Mattsson, Andreas Lundqvist, Elias S.J. Arnér, Rolf Kiessling, Stina L. Wickström - Journal for ImmunoTherapy of Cancer 2022 被引用: 62

  6. Coexpressed Catalase Protects Chimeric Antigen Receptor–Redirected T Cells as well as Bystander Cells from Oxidative Stress–Induced Loss of Antitumor Activity

    著者: Maarten A. Ligtenberg, Dimitrios Mougiakakos, Madhura Mukhopadhyay, Kristina Witt, Álvaro Lladser, Markus Chmielewski, Tobias Riët, Hinrich Abken, Rolf Kiessling - The Journal of Immunology 2015 被引用: 212

  7. „Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell

    著者: Rolf Kiessling, Eva Klein, Hugh F. Pross, Hans Wigzell - European Journal of Immunology 1975 被引用: 1,116

  8. Classification of current anticancer immunotherapies

    著者: Lorenzo Galluzzi, Erika Vacchelli, José Manuel Bravo‐San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean‐Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa M. Coussens, Madhav V. Dhodapkar, Alexander Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek D. Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Paweł Kaliński, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, J P Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J.M. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, A. Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer A. Rizvi, Catherine Sautès‐Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva‐Santos, Mark J. Smyth, Daniel E. Speiser, Radek Špíšek, Pramod K. Srivastava, James E. Talmadge, Éric Tartour, Sjoerd H. van der Burg, Benoı̂t J. Van den Eynde, Richard G. Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou, Guido Kroemer - Oncotarget 2014 被引用: 470

  9. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis

    著者: Shiyong Neo, Le Tong, Joni Chong, Yaxuan Liu, Jing Xu, Mariana M.S. Oliveira, Yi Chen, Ziqing Chen, Keene Lee, Nutsa Burduli, Xinsong Chen, Juan Gao, Ran Ma, Jia Pei Lim, Jianxin Huo, Shengli Xu, Evren Alici, Stina L. Wickström, Felix Haglund, Johan Hartman, Arnika Kathleen Wagner, Yihai Cao, Rolf Kiessling, Kong‐Peng Lam, Lisa S. Westerberg, Andreas Lundqvist - Science Translational Medicine 2024 被引用: 70

  10. Trogocytosis and fratricide killing impede MSLN-directed CAR T cell functionality

    著者: Esther Schoutrop, Stefanie Renken, Isabella Micallef Nilsson, Paula Hahn, Thomas Poiret, Rolf Kiessling, Stina L. Wickström, Jonas Mattsson, Isabelle Magalhaes - OncoImmunology 2022 被引用: 38

  11. Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress

    著者: Dimitrios Mougiakakos, C. Christian Johansson, Regina Jitschin, Martin Böttcher, Rolf Kiessling - Blood 2010 被引用: 163

  12. Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma

    著者: Yago Pico de Coaña, Maria Wolodarski, Isabel Poschke, Yuya Yoshimoto, Yuan Yang, Maria Nyström, Ulrika Edbäck, Suzanne Eghyazi Brage, Andreas Lundqvist, Giuseppe Masucci, Johan Hansson, Rolf Kiessling - Oncotarget 2017 被引用: 142

  13. The Outcome of Ex Vivo TIL Expansion Is Highly Influenced by Spatial Heterogeneity of the Tumor T-Cell Repertoire and Differences in Intrinsic In Vitro Growth Capacity between T-Cell Clones

    著者: Isabel Poschke, Jessica C. Hassel, Aaron Rodriguez-Ehrenfried, Katharina A.M. Lindner, Ignacio Heras‐Murillo, Lena M. Appel, Johanna Lehmann, Tanja Lövgren, Stina L. Wickström, Claudia Lauenstein, Jasmin Roth, Anna‐Katharina König, John B.A.G. Haanen, Joost van den Berg, Rolf Kiessling, Frank Bergmann, Michael Floßdorf, Oliver Strobel, Rienk Offringa - Clinical Cancer Research 2020 被引用: 90

  14. Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity

    著者: Yumeng Mao, Dhifaf Sarhan, André Steven, Barbara Seliger, Rolf Kiessling, Andreas Lundqvist - Clinical Cancer Research 2014 被引用: 269

  15. Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells

    著者: Mattias Carlsten, Håkan Norell, Yenan T. Bryceson, Isabel Poschke, Kjell Schedvins, Hans‐Gustaf Ljunggren, Rolf Kiessling, Karl‐Johan Malmberg - The Journal of Immunology 2009 被引用: 276

  16. The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations

    著者: Birgitta Agerberth, Jehad Charo, Joachim Werr, Berit Olsson, Farah Idali, Lennart Lindbom, Rolf Kiessling, Hans Jörnvall, Hans Wigzell, Guðmundur H. Guðmundsson - Blood 2000 被引用: 748

  17. Regulatory T Cells in Cancer

    著者: Dimitrios Mougiakakos, Aniruddha Choudhury, Álvaro Lladser, Rolf Kiessling, C. Christian Johansson - Advances in cancer research 2010 被引用: 382

  18. Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

    著者: Anna Kruschinski, Andreas Moosmann, Isabel Poschke, Håkan Norell, Markus Chmielewski, Barbara Seliger, Rolf Kiessling, Thomas Blankenstein, Hinrich Abken, Jehad Charo - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 被引用: 195

  19. Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress–induced cell death

    著者: Dimitrios Mougiakakos, C. Christian Johansson, Rolf Kiessling - Blood 2008 被引用: 187

  20. Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms

    著者: Yumeng Mao, Isabel Poschke, Erik Wennerberg, Yago Pico de Coaña, Suzanne Egyházi Brage, Inkeri Schultz, Johan Hansson, Giuseppe Masucci, Andreas Lundqvist, Rolf Kiessling - Cancer Research 2013 被引用: 186

  21. Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

    著者: Tanja Lövgren, Maria Wolodarski, Stina L. Wickström, Ulrika Edbäck, Mette Wallin, Eva Martell, Katrin Markland, Pontus Blomberg, Maria Nyström, Andreas Lundqvist, Hans Jacobsson, Gustav Ullenhag, Per Ljungman, Johan Hansson, Giuseppe Masucci, Roger Tell, Isabel Poschke, Lars Adamson, Jonas Mattsson, Rolf Kiessling - OncoImmunology 2020 被引用: 50

  22. Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated cytotoxicity

    著者: Koji Kono, Flavio Salazar‐Onfray, Max Petersson, Johan Hansson, Giuseppe Masucci, Ken Wasserman, Tsutomu Nakazawa, Paul Anderson, Rolf Kiessling - European Journal of Immunology 1996 被引用: 361

  23. Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma

    著者: Yumeng Mao, Nina Eißler, Katarina Le Blanc, John Inge Johnsen, Per Kogner, Rolf Kiessling - Clinical Cancer Research 2016 被引用: 141

  24. Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production

    著者: Yago Pico de Coaña, Isabel Poschke, Giusy Gentilcore, Yumeng Mao, Maria Nyström, Johan Hansson, Giuseppe Masucci, Rolf Kiessling - Cancer Immunology Research 2013 被引用: 138